Biomarkers in the age of omics: time for a systems biology approach
about
Visualization and curve-parameter estimation strategies for efficient exploration of phenotype microarray kineticsComputational Tools for Parsimony Phylogenetic Analysis of Omics Data.A Systems Biology Interpretation of Array Comparative Genomic Hybridization (aCGH) Data through Phylogenetics.The environment ontology: contextualising biological and biomedical entitiesMarkers for nutrition studies: review of criteria for the evaluation of markers.Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients.Proteomics analysis of hepatoprotective effects for scoparone using MALDI-TOF/TOF mass spectrometry with bioinformaticsProtein interactome of muscle invasive bladder cancer.Identifying pathological biomarkers: histochemistry still ranks high in the omics era.Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics.Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effectsIdentifying early events of gene expression in breast cancer with systems biology phylogenetics.Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.Systems Biology Profiling of AMD on the Basis of Gene Expression.Stress, genomic adaptation, and the evolutionary trade-off.Methodological implications of nonlinear dynamical systems models for whole systems of complementary and alternative medicine.Allostasis in nonalcoholic fatty liver disease: implications for risk assessment.Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology.Circulating microRNA biomarkers for glioma and predicting response to therapy.Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome.BcCluster: A Bladder Cancer Database at the Molecular Level.Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples.A multi-omic analysis reveals the regulatory role of CD180 during the response of macrophages to Borrelia burgdorferi.Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia
P2860
Q21134690-D67092A2-C77E-461B-BCD4-AEEF662A5AF2Q30984260-6036A028-244A-4FC4-9E97-09DD3BD9C994Q31059207-136F9D86-4793-4EDA-BD94-4D4F05D63A16Q31110188-78343A32-D9F9-403F-A9B6-39D4F0E9D67CQ34364879-CEB3829C-3268-4CB0-813F-50E7E8B240CAQ34373935-313B40F3-3C8D-4686-A3A5-2CCB5E214C7AQ34628636-621939DB-49D8-4B70-8E57-06B0551338F9Q34876528-35FBE798-FB43-446A-A90F-C66C182625C6Q35771448-01C55E7B-C3C0-430F-8448-81859D592B01Q36403283-DF7B0A54-3B16-4125-8883-9C1599B4E935Q36515121-F482214E-B894-4954-982F-8ECB6E046A18Q36900433-23480CA0-1F24-4F99-9C72-6298F19E445DQ37113859-DA86E9B5-572D-4B58-8A29-DD221E1CD2BCQ37365352-89037417-BE28-4BE6-AD10-F11792B23C08Q37734822-F3BC1FA5-0676-432B-8AB2-68BDF094CAD9Q37983422-5FAC5BB2-2EA6-4DBD-B47B-BCC118095673Q38034114-28C98B26-2EE9-44FF-A87A-746F36B817FCQ38120648-B0F47432-F06E-4E84-876B-93CC56B9BE5CQ38201683-000FCB6C-163D-4BF5-BB52-2921903C5AA2Q38270771-8125B0CB-6A01-4417-AB87-C37BD34DCC76Q38366733-542CF72C-678C-448A-806E-33AA88BD5205Q38825662-C7CD42A8-0695-4B77-953B-ABB7C4DEDC52Q39036457-1183DFD8-A115-4064-B343-8A0ACDB11724Q39634042-A2B4883F-BFC6-42F7-BC9C-09D1DF76764AQ40000942-9502D8C8-B163-4B02-937E-D4E56B416EC1Q49511137-268EE206-B4E8-4015-A5A3-ED94965BDB9BQ55133030-731B5C42-9741-41D3-8EFF-42E4A46091F1Q58705274-AEA6F272-2D8A-4721-B965-A9C34D97CB76
P2860
Biomarkers in the age of omics: time for a systems biology approach
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biomarkers in the age of omics: time for a systems biology approach
@ast
Biomarkers in the age of omics: time for a systems biology approach
@en
Biomarkers in the age of omics: time for a systems biology approach
@nl
type
label
Biomarkers in the age of omics: time for a systems biology approach
@ast
Biomarkers in the age of omics: time for a systems biology approach
@en
Biomarkers in the age of omics: time for a systems biology approach
@nl
prefLabel
Biomarkers in the age of omics: time for a systems biology approach
@ast
Biomarkers in the age of omics: time for a systems biology approach
@en
Biomarkers in the age of omics: time for a systems biology approach
@nl
P2093
P2860
P50
P356
P1476
Biomarkers in the age of omics: time for a systems biology approach
@en
P2093
Fouad Atouf
Hakima Amri
Majid Laassri
Mohamed Chaouchi
Salvatore Alesci
Susana Galli
P2860
P304
P356
10.1089/OMI.2010.0023
P577
2011-02-14T00:00:00Z